Application no. and date | 10735198.3 (espacenet) (Federated) (European Patent Register), 20100707 | Patent/reg. no. and date | DK/EP 2432798, 20130403 | Publication date | 20120328 | Priority no. and date | DE 102009034362, 20090720 | EP pub. no. and date |
EP 2432798 20120328 | Effective date | | Applicant/owner | Bayer Intellectual Property GmbH, Alfred-Nobel-Str. 50 40789 Monheim am Rhein, DE | Applicant ref. no. | BAYER BHC093030PCT-EP | Inventor | ROTGERI, Andrea, Damwildsteig 21
13503 Berlin, DE, Schwede, Wolfgang, Magdeburger Str. 41a
16548 Glienicke, DE, Möller, Carsten, Pflugstr. 9a
10115 Berlin, DE, BONE, Wilhelm, Drewitzer Str. 46
13467 Berlin, DE, KLAR, Ulrich, Isegrimsteig 8
13503 Berlin, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/567 (2006.01) , A61P 5/36 (2006.01) , C07J 31/00 (2006.01) , C07J 41/00 (2006.01) | Title | 17-HYDROXY-17-PENTAFLOURETHYL-ESTRA-4,9(10)-DIEN-11-ARYL-DERIVAT, FREMGANGSMÅDE TIL FREMSTILLING HERAF OG ANVENDELSE HERAF TIL BEHANDLING AF SYGDOMME | Int. application no. | EP2010004149 | Int. publication no. | WO2011009531 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|